These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 35913859

  • 21. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D, Bhattacharya A, Mete UK, Mittal BR.
    Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
    [Abstract] [Full Text] [Related]

  • 22. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I, Kuisma A, Ramadan S, Huovinen R, Sandell M, Kajander S, Kemppainen J, Kauppila E, Auren J, Merisaari H, Saunavaara J, Noponen T, Minn H, Aronen HJ, Seppänen M.
    Acta Oncol; 2016 Aug; 55(1):59-67. PubMed ID: 25833330
    [Abstract] [Full Text] [Related]

  • 23. Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients.
    Letellier A, Johnson AC, Kit NH, Savigny JF, Batalla A, Parienti JJ, Aide N.
    Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
    [Abstract] [Full Text] [Related]

  • 24. Quantitative assessment of 99mTc-methylene diphosphonate bone SPECT/CT for assessing bone metastatic burden and its prognostic value in patients with castration-resistant prostate cancers: initial results in a single-center retrospective study.
    Oya T, Ichikawa Y, Nakamura S, Tomita Y, Sasaki T, Inoue T, Sakuma H.
    Ann Nucl Med; 2023 Jun; 37(6):360-370. PubMed ID: 36947324
    [Abstract] [Full Text] [Related]

  • 25. Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer.
    Arvola S, Jambor I, Kuisma A, Kemppainen J, Kajander S, Seppänen M, Noponen T.
    EJNMMI Res; 2019 Jan 24; 9(1):6. PubMed ID: 30680469
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
    An YS, Park DY, Min BH, Lee SJ, Yoon JK.
    BMC Med Imaging; 2021 Mar 26; 21(1):60. PubMed ID: 33771130
    [Abstract] [Full Text] [Related]

  • 28. Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
    Pietrzak AK, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Urol J; 2018 Sep 26; 15(5):242-247. PubMed ID: 29681049
    [Abstract] [Full Text] [Related]

  • 29. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN, Cimmino A, Altini C, Notaristefano A, Rubini G.
    Hell J Nucl Med; 2011 Sep 26; 14(3):311-2. PubMed ID: 22087457
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Standardized uptake values of 99mTc-MDP in normal vertebrae assessed using quantitative SPECT/CT for differentiation diagnosis of benign and malignant bone lesions.
    Qi N, Meng Q, You Z, Chen H, Shou Y, Zhao J.
    BMC Med Imaging; 2021 Feb 27; 21(1):39. PubMed ID: 33639883
    [Abstract] [Full Text] [Related]

  • 32. Sodium [¹⁸F]fluoride PET/CT in myocardial infarction.
    Han JH, Lim SY, Lee MS, Lee WW.
    Mol Imaging Biol; 2015 Apr 27; 17(2):214-21. PubMed ID: 25281410
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
    Poulsen MH, Petersen H, Høilund-Carlsen PF, Jakobsen JS, Gerke O, Karstoft J, Steffansen SI, Walter S.
    BJU Int; 2014 Dec 27; 114(6):818-23. PubMed ID: 24314065
    [Abstract] [Full Text] [Related]

  • 35. Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT.
    Janssen JC, Meißner S, Woythal N, Prasad V, Brenner W, Diederichs G, Hamm B, Makowski MR.
    Eur Radiol; 2018 Feb 27; 28(2):610-619. PubMed ID: 28779400
    [Abstract] [Full Text] [Related]

  • 36. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW, Lee SM, Lee HS, Kim YH, Bae WK.
    Ann Nucl Med; 2012 Oct 27; 26(8):627-33. PubMed ID: 22729551
    [Abstract] [Full Text] [Related]

  • 37. Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients.
    Mohd Rohani MF, Mat Nawi N, Shamim SE, Wan Sohaimi WF, Wan Zainon WMN, Musarudin M, Said MA, Hashim H.
    Ann Nucl Med; 2020 Jan 27; 34(1):39-48. PubMed ID: 31612417
    [Abstract] [Full Text] [Related]

  • 38. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
    Lin C, Bradshaw T, Perk T, Harmon S, Eickhoff J, Jallow N, Choyke PL, Dahut WL, Larson S, Humm JL, Perlman S, Apolo AB, Morris MJ, Liu G, Jeraj R.
    J Nucl Med; 2016 Dec 27; 57(12):1872-1879. PubMed ID: 27445292
    [Abstract] [Full Text] [Related]

  • 39. Accurate characterization of 99mTc-MDP uptake in extraosseous neoplasm mimicking bone metastasis on whole-body bone scan: contribution of SPECT/CT.
    Zhang L, He Q, Zhou T, Zhang B, Li W, Peng H, Zhong X, Ma L, Zhang R.
    BMC Med Imaging; 2019 May 30; 19(1):44. PubMed ID: 31146746
    [Abstract] [Full Text] [Related]

  • 40. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
    Gedik GK, Ata O, Karabagli P, Sari O.
    Hell J Nucl Med; 2014 May 30; 17(3):214-7. PubMed ID: 25397627
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.